An Analysis of Federal Sickle Cell Disease Program FY 1971 - FY 1976 Page: 13
53 p.View a full description of this report.
Extracted Text
The following text was automatically extracted from the image on this page using optical character recognition software:
CRS - 13
the intent of the Congress to discover the levels and sources of support for si :le
cell disease projects gradually emerges in a review of the appropriations hearings
between FT 1971 and FY 1975 (See Appendix I of this report). Budgetary inform nation
provided in oral testimony closely resembles the levels of support cited in Tables I
and II above.
In FY 1972, oral testimony before the Senate Committee on Appropriations included
this statement: "There are some increases in NULI budget for sickle cell an nia, eon
modest increases in the area of arteriosclerosis. Because the total budget remains
the same, it means the increases in those areas are having to be squeezed out of some
other areas." 7
During the FY 1973 hearings, oral testimony and prepared justification statements
included a detailed accounting of support for the Sickle Cell Disease Program by
institute and by program component.
Oral testimony in FY 1974 clarified the relative costs of research and service
in the Sickle Cell Disease Program: In the Comprehensive Centers for Research and
Service, 40% of the cost is applied to research activities and 60% toward service
activities. Research and development contracts support controlled studies of therapy,
basic studies of molecular structure and various complications of sickle cell anemia.
Biomedical research project grants support meritorious research on sickle cell anemia;
this research is recommended by other NIH institutes, but is funded by NHLI. j/
In FT 1973 and FY 1974, justifications statements prepared by NHLI reported that
any increases requested for the Sickle Cell Disease Program were completely included and
7 / U.S. Congress. Senate. Committee on Appropriations. Departments of Labor, and
- Health, Education, and Welfare Appropriations. Hearings, 92nd Congress, 1st ses-
sion, on H.R. 10061. Part 6. Washington, U.S. Govt. Print. Off., 1971. p. 3752.U.S. Congress. House. Committee on Appropriations. Departments of Labor, and
Health, Education, and Welfare Appropriations for 1974. Hearings, 93rd Congress
1st session. Part 4. Washington, U.S. Govt. Print. Off., 1973. p. 307-311.
77 ' 7-1W7
Upcoming Pages
Here’s what’s next.
Search Inside
This report can be searched. Note: Results may vary based on the legibility of text within the document.
Tools / Downloads
Get a copy of this page or view the extracted text.
Citing and Sharing
Basic information for referencing this web page. We also provide extended guidance on usage rights, references, copying or embedding.
Reference the current page of this Report.
Chapman, Cynthia B. An Analysis of Federal Sickle Cell Disease Program FY 1971 - FY 1976, report, April 11, 1975; Washington D.C.. (https://digital.library.unt.edu/ark:/67531/metadc992938/m1/15/: accessed July 16, 2024), University of North Texas Libraries, UNT Digital Library, https://digital.library.unt.edu; crediting UNT Libraries Government Documents Department.